Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
about
Clinical Phenotypes in Heart Failure With Preserved Ejection FractionTetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin TetramerCardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.Systemic amyloidosis: novel therapies and role of biomarkers.Newer Therapies for Amyloid Cardiomyopathy.Gastrointestinal Amyloidosis: Review of the Literature.Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Hereditary Amyloidosis with Recurrent Lung InfiltratesA Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy.Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.Transthyretin familial amyloid polyneuropathy: an update.Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses.Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosis.Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.Incidence of nonamyloidogenic mutations in the transthyretin gene in patients with autonomic and small fiber neuropathy.Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study.Recurrent Syncope, a Clue in Amyloid Cardiomyopathy.Catechol-Containing Hydroxylated Biomimetic 4-Thiaflavanes as Inhibitors of Amyloid Aggregation.Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
P2860
Q28073079-D2C7E924-2E76-44A8-AEFB-85B950B5125FQ28551432-7FCAD5EE-08C6-45D5-A266-7BED824BDAA5Q38663987-23664AB3-1B71-4D8B-90B4-EB8407A45224Q38745211-492E9EE6-8328-460A-BF59-01A4AEC19CC1Q38829923-22D80E43-73A8-4910-959E-F2723565C518Q38920614-E00E8B38-EC20-48EA-AA0A-EF79FB4B70FFQ39371045-AEE1F6E1-0495-4CC9-A93E-2AB38EA1A70BQ40081734-09826434-7692-498B-AEB0-C850C99BAF25Q41106725-BCD995C9-E910-4906-B45B-DA609E2A4E84Q42028616-5472FCB1-2001-49B7-BAC5-E81D6F0DDCF5Q42290906-99B0269D-5D40-46C7-BBD3-0E8646B1375FQ47361404-338C0234-8E8C-4E88-9230-77A2EF47AF80Q47562649-407E7DF9-2163-4C3C-8CBE-16FA5B8E5AC3Q48113077-61C8EA52-DEA5-4FE9-93C3-DD47ED8165BBQ48628498-9449549E-04A3-4935-A802-D39BD8770C71Q49960443-C35530B9-5AF5-483B-830A-6D09B29DE2ECQ50093227-922ECCA1-6526-45A2-88C0-0814B7BE581AQ50212765-9C1C437B-9CEB-4780-9403-CBD80B23A1DEQ50972153-BFD45D50-029A-4935-8B16-2E53EF011E13Q51050465-DC7BEBAE-F999-467C-B24D-10C6250BDADAQ52645922-52383B45-0F83-4B5E-86D4-8C2C71D39675Q56838058-8518CC36-BDFE-4FB1-A071-6B87E6EAEA17Q58773826-79732E42-EEA1-4DC8-9696-4A873452C1D3
P2860
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@ast
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@en
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@nl
type
label
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@ast
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@en
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@nl
prefLabel
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@ast
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@en
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@nl
P2093
P50
P3181
P1476
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
@en
P2093
John L Berk
Marcia Cruz
Martha Grogan
Merrill D Benson
Peter J Dyck
Terresa Coelho
Violaine Plante-Bordeneuve
P304
P3181
P356
10.1016/J.JACC.2015.09.075
P407
P577
2015-12-01T00:00:00Z